Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes

被引：0
作者：
Joep van der Leeuw
Frank L. J. Visseren
Mark Woodward
Yolanda van der Graaf
Diederick E. Grobbee
Stephen Harrap
Simon Heller
Giuseppe Mancia
Michel Marre
Neil Poulter
Sophia Zoungas
John Chalmers
机构：
[1] University Medical Centre Utrecht,Department of Vascular Medicine
[2] University of Sydney,The George Institute for Global Health
[3] University of Oxford,The George Institute for Global Health, Nuffield Department of Population Health
[4] University Medical Centre Utrecht,Julius Centre for Health Sciences and Primary Care
[5] University of Melbourne,The Royal Melbourne Hospital
[6] University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust,Istituto Auxologico Italiano
[7] University of Milano-Bicocca,International Centre for Circulatory Health
[8] Hôpital Bichat-Claude Bernard and Université Paris 7,undefined
[9] Imperial College,undefined
来源：
Diabetologia | 2016年 / 59卷
关键词：
Glycaemic target; Hypoglycaemia; Net benefit; Personalised medicine; Type 2 diabetes; Vascular complications;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2603 / 2612
页数：9
相关论文
共 50 条
  • [21] Devoting attention to glucose variability and hypoglycaemia in type 2 diabetes
    Martin K. Rutter
    Diabetologia, 2018, 61 : 43 - 47
  • [22] Estimation of the onset time of diabetic complications in type 2 diabetes patients in Thailand: a survival analysis
    Sauenram, Natthanicha
    Sillabutra, Jutatip
    Viwatwongkasem, Chukiat
    Satitvipawee, Pratana
    OSONG PUBLIC HEALTH AND RESEARCH PERSPECTIVES, 2023, 14 (06) : 508 - 519
  • [23] Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: association with hypoglycaemic events
    Farmer, Andrew
    Balman, Elizabeth
    Gadsby, Roger
    Moffatt, Jane
    Cradock, Sue
    McEwen, Lisa
    Jameson, Kevin
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (11) : 3097 - 3104
  • [24] Type 2 diabetes in patients older than 70 years - aspects of metabolic control
    Rymkiewicz, Emilia
    Dzida, Grzegorz
    CLINICAL DIABETOLOGY, 2018, 7 (02): : 97 - 101
  • [25] The ACCORD Trial and Control of Blood Glucose Level in Type 2 Diabetes Mellitus Time to Challenge Conventional Wisdom
    Havas, Stephen
    ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (02) : 150 - 154
  • [26] Dose-response relationship between sulfonylureas and major adverse cardiovascular events in elderly patients with type 2 diabetes
    Abdelmoneim, Ahmed S.
    Eurich, Dean T.
    Senthilselvan, Ambikaipakan
    Qiu, Weiyu
    Simpson, Scot H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (10) : 1186 - 1195
  • [27] Hospital-acquired complications in intensive care unit patients with diabetes: A before-and-after study of a conventional versus liberal glucose control protocol
    Luethi, Nora
    Cioccari, Luca
    Eastwood, Glenn
    Biesenbach, Peter
    Morgan, Rhys
    Sprogis, Stephanie
    Young, Helen
    Peck, Leah
    Chong, Christine Knee
    Moore, Sandra
    Moon, Kylie
    Ekinci, Elif I.
    Deane, Adam M.
    Bellomo, Rinaldo
    Martensson, Johan
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2019, 63 (06) : 761 - 768
  • [28] Angiogenic effects of Type 2 diabetes on the dental pulp
    Patel, S.
    Yang, E.
    Milne, T. J.
    Hussaini, H.
    Cooper, P. R.
    Friedlander, L. T.
    INTERNATIONAL ENDODONTIC JOURNAL, 2025, 58 (03) : 434 - 448
  • [29] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Kalyani, Rita R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13) : 1248 - 1260
  • [30] Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes
    den Ouden, Henk
    Pellis, Linette
    Rutten, Guy E. H. M.
    Geerars-van Vonderen, Ilse K.
    Rubingh, Carina M.
    van Ommen, Ben
    van Erk, Marjan J.
    Beulens, Joline W. J.
    METABOLOMICS, 2016, 12 (02) : 1 - 9
12345